Submissions from 2020
Heart disease and stroke statistics-2020 update: A report from the American Heart Association, Salim S. Virani, Alvaro Alonso, Emelia J. Benjamin, Marcio S. Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Alexander R. Chang, Susan Cheng, and Francesca N. Delling
Secondary prevention for atherosclerotic cardiovascular disease: Comparing recent US and European guidelines on dyslipidemia, Salim S. Virani, Sidney C. Smith Jr, Neil J. Stone, and Scott M. Grundy
Association between intensity of statin therapy and mortality in persons with chronic kidney disease, Carl P. Walther, Peter A. Richardson, Salim S. Virani, Wolfgang C. Winkelmayer, and Sankar D. Navaneethan
Stroke in young adults: Current trends, opportunities for prevention and pathways forward, Tamer Yahya, Mohammad Hashim Jilani, Safi U. Khan, Reed Mszar, Syed Zawahir Hassan, Michael J. Blaha, Ron Blankstein, Salim S. Virani, and Michelle C. Johansen
Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression, Emir Yonas, Idrus Alwi, Raymond Pranata, Ian Huang, Michael Anthonius Lim, Muhammad Yamin, Sally Aman Nasution, Siti Setiati, and Salim S. Virani
Operability, usefulness, and task-technology fit of an mHealth App for delivering primary health care services by community health workers in underserved areas of Pakistan and Afghanistan: Qualitative study, Shehla Zaidi, Abdul Momin Kazi, Atif Riaz, Ammarah Ali, Rabia Najmi Taha, Rawshan Jabeen, Umerdad Khudadad, and Saleem Sayani
Operability, acceptability, and usefulness of a mobile app to track routine immunization performance in rural Pakistan: Interview study among vaccinators and key informants, Shehla Zaidi, Saqib Ali Shaikh, Saleem Sayani, Abdul Momin Kazi, Adeel Khoja, Syed Shahzad Hussain, and Rabia Najmi
A way to track governments’ response and people’s mobility changes in response to COVID-19 pandemic, Dongshan Zhu, Shiva Raj Mishra, and Salim S. Virani
Submissions from 2019
Popular media and cardiovascular medicine: “with Great Power There Must Also Come Great Responsibility”, Anandita Agarwala, Payal Kohli, and Salim S. Virani
The use of risk-enhancing factors to personalize ASCVD risk assessment: evidence and recommendations from the 2018 AHA/ACC multi-society cholesterol guidelines, Anandita Agarwala, Jing Liu, Christie M. Ballantyne, and Salim S. Virani
Primary and secondary prevention of cardiovascular disease in patients with chronic kidney disease, Sehrish Ali, Natasha Dave, Salim S. Virani, and Sankar D. Navaneethan
Major randomized clinical trials in cardiovascular disease prevention presented at the 2019 American College of Cardiology annual scientific session, Mahmoud Al Rifai, Xiaoming Jia, Mouaz H. Al-Mallah, Michael D. Miedema, Seth S. Martin, and Salim S. Virani
The interplay of the global atherosclerotic cardiovascular disease risk scoring and cardiorespiratory fitness for the prediction of all-cause mortality and myocardial infarction: The Henry Ford ExercIse testing project (The FIT Project), Mahmoud Al Rifai, Waqas T. Qureshi, Zeina Dardari, Steven J. Keteyian, Clinton A. Brawner, Jonathan K. Ehrman, Amjad Ahmed, Sherif Sakr, Salim S. Virani, and Michael J. Blaha
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association, Emelia J. Benjamin, Paul Muntner, Alvaro Alonso, Marcio S. Bittencourt, Clifton W. Callaway, April P. Carson, Alanna M. Chamberlain, Alexander R. Chang, Susan Cheng, and Salim S. Virani
Health and sustainable development goals for Pakistan, Zulfiqar Ahmed Bhutta and Jai K. Das
Patient-reported reasons for declining or discontinuing statin therapy: Insights from the PALM registry, Corey K. Bradley, Tracy Y. Wang, Shuang Li, Jennifer G. Robinson, Veronique L. Roger, Anne C. Goldberg, Salim S. Virani, Michael J. Louie, L Veronica Lee, and Eric D. Peterson
Four cases of cholesterol management informed by the 2018 American Heart Association/American College of Cardiology multisociety guideline on the management of blood cholesterol, Sarah Chuzi, Anna Pfenniger, Donald M. Lloyd-Jones, Roger S. Blumenthal, Sidney C Smith Jr C. Smith Jr, Salim S. Virani, Scott M. Grundy, and Neil J. Stone
2018 Cholesterol guidelines: Key topics in primary prevention, Donald Clark 3rd and Salim S. Virani
Therapeutic inertia in cardiovascular disease prevention: Time to move the bar, Dave L. Dixon, Garima Sharma, Pratik B. Sandesara, Eugene Yang, Lynne T. Braun, George A. Mensah, Laurence S. Sperling, Prakash C. Deedwania, and Salim S. Virani
Mortality reduction with PCSK9 inhibition: A case of cautious optimism, Dave L. Dixon and Salim S. Virani
Canada in a global system of higher education: The role of community engagement, Brent Epperson, Britta Baron, and Carl Amrhein
Low levels of ideal cardiovascular health in a semi-urban population of Western Nepal: A population-based, cross-sectional study, Bishal Gyawali, Shiva Raj Mishra, Salim S. Virani, and Per Kallestrup
Association of body mass index with risk factor optimization and guideline-directed medical therapy in US veterans with cardiovascular disease, Ravi S. Hira, Akash Kataruka, Julia M. Akeroyd, David J. Ramsey, Yashashwi Pokharel, Hitinder S. Gurm, Khurram Nasir, Anita Deswal, Hani Jneid, and Salim S. Virani
Risk assessment of stroke in patients with atrial fibrillation: Current shortcomings and future directions, Daniel A. Hyman, Vincent Siebert, Xiaoming Jia, Mahboob Alam, Glenn N. Levine, Salim S. Virani, and Yochai Birnbaum
Eligibility and cost for Icosapent ethyl based on the REDUCE-IT trial, Xiaoming Jia, Julia M. Akeroyd, Khurram Nasir, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, and Salim S. Virani
Highlights from selected cardiovascular disease prevention studies presented at the 2019 European Society of Cardiology Congress, Xiaoming Jia, Mahmoud Al Rifai, Ty J. Gluckman, Yochai Birnbaum, and Salim S. Virani
Association between lipid testing and statin adherence in the Veterans affairs health system, Xiaoming Jia, Mahmoud Al Rifai, David J. Ramsey, Sarah T. Ahmed, Julia M. Akeroyd, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, Neil J. Stone, and Salim S. Virani
The 2018 cholesterol management guidelines: Topics in secondary ASCVD prevention clinicians need to know, Xiaoming Jia, Mahmoud Al Rifa, Yochai Birnbaum, Sidney C. Smith Jr, and Salim S. Virani
Omega-3 fatty acid and cardiovascular outcomes: Insights from recent clinical trials, Xiaoming Jia, Payal Kohli, and Salim S. Virani
CLEAR serenity trial: More clarity for the future of bempedoic acid in patients unable to take statins?, Xiaoming Jia and Salim S. Virani
The potential of m-Health-based interventions to improve medication literacy and adherence in non-communicable diseases in Pakistan, Ayeesha Kamran Kamal, Wardah Khalid, Maryam Zulfiqar, Abdul Muqeet, Fabiha Zaidi, Ambreen Gowani, and Salim S. Virani
Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside, Dhruv S. Kazi and Salim S. Virani
Prescription patterns of clopidogrel, prasugrel, and ticagrelor after percutaneous coronary intervention with stent implantation (from the NCDR PINNACLE Registry), Umair Khalid, Salman Bandeali, Philip G. Jones, Salim S. Virani, Ravi Hira, Ihab Hamzeh, Paul S. Chan, Neal S. Kleiman, Nasser Lakkis, and Mahboob Alam
Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression, Mahin R. Khan, Waleed T. Kayani, Waqas Ahmad, Malalai Manan, Ravi S. Hira, Ihab Hamzeh, Hani Jneid, Salim S. Virani, Neal Kleiman, and Nasser Lakkis
Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017, Rohan Khera, Javier Valero-Elizondo, Sandeep R. Das, Salim S. Virani, Bita A. Kash, James A. de Lemos, Harlan M. Krumholz, and Khurram Nasir
Association of clinician knowledge and statin beliefs with statin therapy use and lipid levels (A Survey of US Practice in the PALM Registry), Angela Lowenstern, Ann Marie Navar, Shuang Li, Salim S. Virani, Anne C. Goldberg, Michael J. Louie, L Veronica Lee, Eric D. Peterson, and Tracy Y. Wang
Variation and disparities in awareness of myocardial infarction symptoms among adults in the United States, Shiwani Mahajan, Javier Valero-Elizondo, Rohan Khera, Nihar R. Desai, Ron Blankstein, Michael J. Blaha, Salim S. Virani, Bita A. Kash, William A. Zoghbi, and Harlan M. Krumholz
Emerging lipid-lowering therapies in secondary prevention, Dhruv Mahtta, Salim S. Virani, and Anthony A. Bavry
Childhood oral infections and subclinical atherosclerosis in adulthood: Should we wait for causality or just treat?, Anwar T. Merchant and Salim S. Virani
Cardio-metabolic disease risk factors among south Asian labour migrants to the Middle East: A scoping review and policy analysis, Shiva Raj Mishra, Saruna Ghimire, Chandni Joshi, Bishal Gyawali, Archana Shrestha, Dinesh Neupane, Sudesh Raj Sharma, Yashashwi Pokharel, and Salim S. Virani
Socio-economic inequalities in hypertension burden and cascade of services: Nationwide cross-sectional study in Nepal, Shiva Raj Mishra, Saruna Ghimire, Nipun Shrestha, Archana Shrestha, and Salim S. Virani
Combating non-communicable diseases: Potentials and challenges for community health workers in a digital age, a narrative review of the literature, Shiva Raj Mishra, Charilaos Lygidakis, Dinesh Neupane, Bishal Gyawali, Jean Paul Uwizihiwe, Salim S. Virani, Per Kallestrup, and J Jaime Miranda
A roadmap on the prevention of cardiovascular disease among people living with diabetes, Sharon Mitchell, Belma Malanda, Albertino Damasceno, Robert H. Eckel, Dan Gaita, Kornelia Kotseva, James L. Januzzi, George Mensah, Jorge Plutzky, and Salim S. Virani
Cholesterol insights and controversies from the UK biobank study: Three take-home messages for the busy clinician, Samia Mora, Seth S. Martin, and Salim S. Virani
“Zero”: The new superhero or superhero in training?, Vijay Nambi, Salim S. Virani, Peter H. Jones, and Christie M. Ballantyne
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the patient and provider assessment of lipid management (PALM) registry, Michael G. Nanna, Ann Marie Navar, Tracy Y. Wang, Shuang Li, Salim S. Virani, Zhuokai Li, Jennifer G. Robinson, Veronique L. Roger, Peter W F. Wilson, and Anne C. Goldberg
Sex differences in the use of statins in community practice: Patient and provider assessment of lipid management registry, Michael G. Nanna, Tracy Y. Wang, Qun Xiang, Anne C. Goldberg, Jennifer G. Robinson, Veronique L. Roger, Salim S. Virani, Peter W F. Wilson, Michael J. Louie, and Andrew Koren
PCSK9 inhibitors prior authorization: Redundant process due for a redesign, Khurram Nasir, Suveen Angraal, and Salim S. Virani
Spatiotemporal patterns of small for gestational age and low birth weight births and associations with land use and socioeconomic status, Charlene Nielsen, Carl Amrhein, Prakesh S Shah, Khalid Aziz, and Alvaro R Osornio-Vargas
Association of income disparities with patient-reported healthcare experience, Victor Okunrintemi, Rohan Khera, Erica S. Spatz, Joseph A. Salami, Javier Valero-Elizondo, Haider J. Warraich, Salim S. Virani, Ron Blankstein, Michael J. Blaha, and Timothy M. Pawlik
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data, Riyaz S. Patel, Amand F. Schmidt, Vinicius Tragante, Raymond O. McCubrey, Michael V. Holmes, Laurence J. Howe, Kenan Direk, Axel Åkerblom, Karin Leander, and Salim S. Virani
Subsequent event risk in individuals with established coronary heart disease, Riyaz S. Patel, Vinicius Tragante, Amand F. Schmidt, Raymond O. McCubrey, Michael V. Holmes, Laurence J. Howe, Kenan Direk, Axel Åkerblom, Karin Leander, and Salim S. Virani
Meta-analysis of catheter directed ultrasound-assisted thrombolysis in pulmonary embolism, Dorothy T. Pei, Jing Liu, Maidah Yaqoob, Waqas Ahmad, Salman S. Bandeali, Ihab R. Hamzeh, Salim S. Virani, Ravi S. Hira, Nasser M. Lakkis, and Mahboob Alam
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change, Yashashwi Pokharel, Farah Mouhanna, Vijay Nambi, Salim S. Virani, Ron Hoogeveen, Alvaro Alonso, Gerardo Heiss, Josef Coresh, Thomas Mosley, and Rebecca F. Gottesman
High-sensitive troponin T, natriuretic peptide, and cognitive change, Yashashwi Pokharel, Farah Mouhanna, Andrea L C. Schneider, Andreea M. Rawlings, David S. Knopman, Vijay Nambi, Salim S. Virani, Ron C. Hoogeveen, Alvaro Alonso, and Gerardo Heiss
Relation between cardiology follow-up visits, evidence-based statin prescribing, and statin adherence (from the Veterans Affairs Health Care System), Hasan Rehman, Sarah T. Ahmed, Julia Akeroyd, Dhruv Mahtta, Xiaoming Jia, Mahmoud Al Rifai, Khurram Nasir, Hani Jneid, Mirza U. Khalid, and Salim S. Virani
Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease, Fatima Rodriguez, David J. Maron, Joshua W. Knowles, Salim S. Virani, Shoutzu Lin, and Paul A. Heidenreich
Variation in the use of warfarin and direct oral anticoagulants in atrial fibrillation and associated cost implications, Benjamin A. Rodwin, Joseph A. Salami, Erica S. Spatz, Javier Valero-Elizondo, Salim S. Virani, Ron Blankstein, Michael J. Blaha, Khurram Nasir, and Nihar R. Desai
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The atherosclerosis risk in communities study, Anum Saeed, Wensheng Sun, Anandita Agarwala, Salim S. Virani, Vijay Nambi, Josef Coresh, Elizabeth Selvin, Eric Boerwinkle, Peter H. Jones, and Christie M. Ballantyne
Bridging the Gap in Training and Clinical Practice in Sub-Saharan Africa, Mansoor Saleh, Gurudatta Naik, Anne Mwirigi, Asim Jamal, Saleem Sayani, Munir Ghesani, Sheemain Asaria, Aliyah R. Sohani, Shahin Sayed, Zahir Moloo, Karim I. Budhwani, and Zohray Talib
The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk, Pratik B. Sandesara, Salim S. Virani, Sergio Fazio, and Michael D. Shapiro
Adapting a club-based medication delivery strategy to a hypertension context: The CLUBMEDS study in Nigeria, Karla Santo, Godsent C. Isiguzo, Emily Atkins, Shiva R. Mishra, Rajmohan Panda, Lilian Mbau, Samuel B. Fayomi, Collins Ugwu, Augustine Odili, and Salim S. Virani
Provider-level variation in smoking cessation assistance provided in the cardiology clinics: Insights from the NCDR PINNACLE registry, Mayank Sardana, Yuanyuan Tang, Jared W. Magnani, Ira S. Ockene, Jeroan J. Allison, Suzanne V. Arnold, Phillip G. Jones, Thomas M. Maddox, Salim S. Virani, and David D. McManus
Addressing cost and time barriers in chronic disease management through telemedicine: An exploratory research in select low-and middle-income countries, Saleem Sayani, Momina Muzammil, Karima Saleh, Abdul Muqeet, Fabiha Zaidi, and Tehniat Shaikh
Facility-level variation in stress test utilization in veterans with ischemic heart disease, Nishant R. Shah, Sarah T. Ahmed, David E. Winchester, David J. Ramsey, Julia M. Akeroyd, Wen-Chih Wu, Stephen W. Waldo, Richard S. Schofield, Christie M. Ballantyne, and Salim S. Virani
Preventive cardiology as a subspecialty of cardiovascular medicine: JACC council perspectives, Michael D. Shapiro, David J. Maron, Pamela B. Morris, Mikhail Kosiborod, Pratik B. Sandesara, Salim S. Virani, Amit Khera, Christie M. Ballantyne, Seth J. Baum, and Laurence S. Sperling
Understanding by general providers of the echocardiogram report, Amanda Trang, June Kampangkaew, Robin Fernandes, Jasleen Tiwana, Arunima Misra, Ihab Hamzeh, Alvin Blaustein, David Aguilar, Tina Shah, and Salim S. Virani
Gaps in provider lifestyle counseling and its adherence among obese adults with prediabetes and diabetes in the United States, Javier Valero-Elizondo, Ehimen C. Aneni, Chukwuemeka U. Osondu, Gowtham R. Grandhi, Salim S. Virani, and Khurram Nasir
Financial hardship from medical bills among nonelderly U.S. adults with atherosclerotic cardiovascular disease, Javier Valero-Elizondo, Rohan Khera, Anshul Saxena, Gowtham R. Grandhi, Salim S. Virani, Javed Butler, Zainab Samad, Nihar R. Desai, Harlan M. Krumholz, and Khurram Nasir
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs, Salim S. Virani, Julia M. Akeroyd, Sarah T. Ahmed, Chayakrit Krittanawong, Lindsey A. Martin, Jason Slagle, Glenn T. Gobbel, Michael E. Matheny, Christie M. Ballantyne, and Laura A. Petersen
Very High-Risk ASCVD and eligibility for nonstatin therapies based on the 2018 AHA/ACC cholesterol guidelines, Salim S. Virani, JuliaM M. Akeroyd, Sidney C. Smith Jr, Mouaz Al-Mallah, Thomas M. Maddox, Pamela B. Morris, Laura A. Petersen, Christie M. Ballantyne, Scott M. Grundy, and Neil J. Stone
Applicability and cost implications for proprotein convertase subtilisin/kexin type 9 inhibitors based on the odyssey outcomes trial, Salim S. Virani, Julia M. Akeroyd, Vijay Nambi, Erin D. Michos, Pamela B. Morris, Khurram Nasir, Sidney C. Smith Jr, Neil J. Stone, Laura A. Petersen, and Christie M. Ballantyne
Intensity of lipid lowering with statin therapy in patients with cerebrovascular disease versus coronary artery disease: Insights from the PALM registry, Ying Xian, Ann Marie Navar, Shuang Li, Zhuokai Li, Jennifer Robinson, Salim S. Virani, Michael J. Louie, Andrew Koren, Anne Goldberg, and Veronique L. Roger
Medical therapy utilization and long-term outcomes following percutaneous coronary intervention: Five-year results from the veterans affairs clinical assessment, reporting, and tracking system program, Joe X. Xie, Elise C. Gunzburger, Lindsay Kaun, Mary E. Plomondon, Anna E. Barón, Stephen W. Waldo, Salim S. Virani, Thomas M. Maddox, and Kreton Mavromatis
Using m-health applications for improving primary care delivery by community health worker in underserved areas of Pakistan, Shehla Zaidi, Abdul Momin Kazi, Saleem Sayani, Atif Riaz, Rawshan Jabeen, Rabia Najmi Taha, and Ammarah Ali
Using m-health applications for improving primary care delivery by community health worker in underserved areas of Pakistan, Shehla Zaidi, Abdul Momin Kazi, Saleem Sayani, Atif Riaz, Rawshan Jabeen, Rabia Najmi Taha, and Ammarah Ali
Submissions from 2018
Premature coronary heart disease in South Asians: Burden and determinants, Sarah T. Ahmed, Hasan Rehman, Julia M. Akeroyd, Mahboob Alam, Tina Shah, Ankur Kalra, and Salim S. Virani
Ticagrelor use in acute myocardial infarction: Insights from the national cardiovascular data registry, Sukhdeep S. Basra, Tracy Y. Wang, DaJuanicia N. Simon, Karen Chiswell, Salim S. Virani, Mahboob Alam, Vijay Nambi, Ali E. Denktas, Anita Deswal, and Biykem Bozkurt
Heart disease and stroke statistics-2018 update: A report from the American Heart Association, Emelia J. Benjamin, Salim S. Virani, Clifton W. Callaway, Alanna M. Chamberlain, Alexander R. Chang, Susan Cheng, Stephanie E. Chiuve, Mary Cushman, Francesca N. Delling, and Rajat Deo
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline, John D. Bucheit, Haleigh Helsing, Pramit Nadpara, Salim S. Virani, and Dave L. Dixon
Promoting clinical breast evaluations in a lower middle–income country Setting: An approach toward achieving a sustainable breast health program, Roziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, Guldarbogh Sadonshoeva, Saleem Sayani, Aliya Aminmuhammad, Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib
Dynamics of gender justice, conflict and social cohesion: analysing educational reforms in Pakistan, Naureen Durrani and Anjum Halai
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease, Nadeen N. Faza, Julia M. Akeroyd, David J. Ramsey, Tina Shah, Khurram Nasir, Anita Deswal, Christie M. Ballantyne, Laura A. Petersen, and Salim S. Virani
Aberrant course of pacemaker leads: When left is left, Nadeen N. Faza, Salim S. Virani, Vijay Nambi, and Tina Shah
Antihypertensive adherence and outcomes among community-dwelling medicare beneficiaries: The atherosclerosis risk in communities study, Jerome J. Federspiel, Carla A. Sueta, Anna M. Kucharska-Newton, Hadi Beyhaghi, Lei Zhou, Salim S. Virani, and Jo E. Rodgers
Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013, David I. Feldman, Javier Valero-Elizondo, Joseph A. Salami, Jamal S. Rana, Oluseye Ogunmoroti, Victor Okunrintemi, Chukwuemeka U. Osondu, Erica S. Spatz, Salim S. Virani, and Ron Blankstein
Identifying mobile apps targeting palliative care patients and family members, Meredith MacKenzie Greenle, Brianna Morgan, Saleem Sayani, and Salimah H. Meghani
Assessment for learning in Africa: Insights from classrooms in Tanzania, Anjum Halai, Veronica Sarungi, and Therese N. Hopfenbeck
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR research to practice (R2P) project, Paul L. Hess, Kevin Kennedy, Michael Cowherd, Salim S. Virani, Frederick A. Masoudi, Ann Marie Navar, Robert W. Yeh, P Michael Ho, and Thomas M. Maddox
Electronic health records and outpatient cardiovascular disease care delivery: Insights from the American college of cardiology’s PINNACLE India quality improvement program (PIQIP), Ankur Kalra, Deepak L. Bhatt, Jessica Wei, Karen L. Anderson, Stefan Rykowski, Prafulla G. Kerkar, Ganesh Kumar, Thomas M. Maddox, William J. Oetgen, and Salim S. Virani
Making prescriptions “talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study), Ayeesha Kamran Kamal; Wardah Khalid; Abdul Muqeet,; Anum Jamil,; Kashfa Farhat; Sehar Rahim Ali Gillani; Maryam Zulfiqar; Mehreen Saif; Aliya Amin Muhammad; Fabiha Zaidi; Saleem Sayani; and Salim S. Virani
Are universities in the UK meeting the needs and expectations of their international students, including those from East Africa?, Tashmin Khamis
Coming and going in higher education: Faculty motivation and their implications for recruitment and retention strategies, Tashmin Khamis
Measurement of low-density lipoprotein cholesterol levels in primary and secondary prevention patients: Insights from the PALM registry, Angela M. Lowenstern, Shuang Li, Ann Marie Navar, Veronique L. Roger, Jennifer G. Robinson, Anne C. Goldberg, Salim S. Virani, L Veronica Lee, Peter W F Wilson, and Michael J. Louie
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs, Cameron L. McBride, Julia M. Akeroyd, David J. Ramsey, Vijay Nambi, Khurram Nasir, Erin D. Michos, Ruth L. Bush, Hani Jneid, Pamela B. Morris, and Salim S. Virani
Statin eligibility, coronary artery calcium, and subsequent cardiovascular events according to the 2016 United States preventive services task force (USPSTF) statin guidelines: MESA (multi-ethnic study of atherosclerosis), Michael D. Miedema, Zeina A. Dardari, Sina Kianoush, Salim S. Virani, Joseph Yeboah, Joseph Yeboah, Thomas Knickelbine, Veit Sandfort, Carlos J. Rodriguez, Khurram Nasir, and Michael J. Blaha
Statin use and adverse effects among adults >75 years of age: Insights from the patient and provider assessment of lipid management (PALM) registry, Michael G. Nanna, Ann Marie Navar, Tracy Y. Wang, Xiaojuan Mi, Salim S. Virani, Michael J. Louie, L Veronica Lee, Anne C. Goldberg, Veronique L. Roger, and Jennifer Robinson
Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: Insights from the patient and provider assessment of lipid management registry, Michael G. Nanna, Ann Marie Navar, Pearl Zakroysky, Qun Xiang, Anne C. Goldberg, Jennifer Robinson, Veronique L. Roger, Salim S. Virani, Peter W F Wilson, and Joseph Elassal
Facility-level variations in kidney disease care among veterans with diabetes and CKD, Sankar D. Navaneethan, Julia M. Akeroyd, David Ramsey, Sarah T. Ahmed, Shiva Raj Mishra, Laura A. Petersen, Paul Muntner, Christie Ballantyne, Wolfgang C. Winkelmayer, and Salim S. Virani
High-density lipoprotein cholesterol and causes of death in chronic kidney disease, Sankar D. Navaneethan, Jesse D. Schold, Carl P Walther, Susana Arrigain, Stacey E. Jolly, Salim S. Virani, Wolfgang C. Winkelmayer, and Joseph V. Nally Jr